News and Updates
News and Updates
NEWS AND UPDATES
Stay updated with the latest healthcare news
Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare
With this acquisition, Krsnaa aims to provide a comprehensive suite of integrated diagnostic services to cancer and cardiac patients under one roof, the company said in a statement.
NCDRC directs Johnson & Johnson to pay Rs 35 lakh for faulty hip replacement device
But, as the device had a high rate of failure and caused severe injuries to the patients, DePuy voluntarily recalled two devices, ASR XL Acetabular and ASR Hip Resurfacing system in September 2010. The opposite parties, Johnson & Johnson Limited and DePuy Orthopaedics Inc were a group of companies of Johnson & Johnson, USA, a leader in the global orthopaedic industry, said Lohia's plea.
Metropolis Healthcare launches ‘Healthy Heart Meter’ campaign in honour of World Heart Day
The initiative aims to encourage preventive care and raise awareness about heart health. The campaign features a simple 10-question survey to help individuals assess their risk factors based on lifestyle choices, medical history, and basic health indicators. Based on their responses, participants are identified as—low, medium, or high risk as per the heart meter. Those identified as medium risk will be recommended to take a non-fasting lipid profile test, while those at high risk will be suggested to take the comprehensive ‘Truhealth Heart Meter Pack’ which includes various diagnostic tests to assess heart health, with the option of an ECG.
Stryker Launches Next-Gen Surgical Camera in India, Enhancing Visualization Across Specialties
The 1788 platform delivers high-resolution images that enable surgeons to visualize critical anatomy with greater clarity. It features advanced fluorescence imaging capabilities, offering clearer perfusion imaging and detailed visualization of complex anatomical structures, Stryker said.
String test may improve diagnosis, treatment of ulcers: Nobel laureate
The other end of the string travels through the digestive system, collecting samples of mucus and bacteria. The string is removed and analysed. "The string test and quantitative PCR (qPCR) confirm the diagnosis and tell us about the best antibiotic for treatment," he said. "Research on the test is still ongoing, but we know it is showing some promise," he said. The test, if proven, may improve the diagnosis and treatment of ulcers.
Amid mpox outbreak South Korea's PCR system markets to grow at 5% till 2033: GlobalData
As per a market study by GlobalData, amid the rising cases of mpox in the world, coupled development of several new tests is going to have a positive impact and the South Korean PCR systems market is expected to grow at a CAGR of 5 per cent through 2033.
Blood test could identify children at risk of obesity-related conditions, lipid analysis suggests
They analysed blood samples of over 1,300 obese, overweight and normal-weight children and identified new lipid molecules which contribute to health risks like blood pressure, but are not only related with a child's weight.
IRGMA welcomes CDSCO's new guidelines, urges stringent measures to curb substandard gloves import
The association has long been demanding the Quality Control Order (QCO) for gloves to keep substandard imports at bay and urged the government to expedite its process. This will not only help Indian manufacturers but also contribute to the union government’s Make in India initiative to achieve self-sufficiency and reduce dependence on other countries.
The Necessity of Comprehensive Flu Testing Packages to Minimise Repeated Examinations
Comprehensive testing packages with a broad detection capability, ensure that multiple pathogens are identified in one go, which further helps in delivering accurate diagnoses and appropriate treatments. Additionally, these packages play a vital role in public health by monitoring circulating strains, managing influenza outbreaks effectively and minimizing their impact on public health.
FDA recall orders for McGrath Mac’s Medtronic laryngoscope may hurt device sales: GlobalData
According to GlobalData, the decision of the US regulator is likely to hurt Medtronic's sales, which currently occupies approximately 10.3 per cent of the laryngoscope market. This impact is compounded by competition from major players like Ambu, Karl Storz, and Olympus, which hold market shares of 13.4 per cent , 15.1 per cent , and 18.1 per cent , respectively.
Redcliffe Labs launch Gut Microbiome, HealthEx tests to promote preventive healthcare
The Gut Microbiome test is a non-invasive and reliable health test that comprehensively analyses gut health. This test recognises that gut microbiota is unique to every person, varying based on gender, geography, eating habits, culture, genetics, and lifestyle. HealthEx is an advanced blood test that evaluates an individual's DNA to provide detailed health insights into potential risks one may develop due to current lifestyle, diet, and genetic factors.
Artificial heart maker Carmat's shares slide on $11.5 mln capital hike
"The capital increase with a priority period for shareholders that we are launching today is crucial to strengthen our short-term financial structure", CEO Stephane Piat said in a statement.
Redcliffe Labs raises $42 million in Series C funding
The organisation will use the funds to open more labs and collection centres along with an expansion of its home collection network. The company has successfully executed strategic acquisitions in North-Western India and continues to pursue a PAN-India expansion through strategic partnerships and further acquisitions.
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
Founded in 2016 by Musk and a group of engineers, Neuralink is building a brain chip interface that can be implanted within the skull, which it says could eventually help disabled patients to move and communicate again, and also restore vision.
Researchers find new diagnostic algorithm to differentiate between Alzheimer's disease, primary tauopathies
"The new diagnostic algorithm we developed allows physicians to differentiate with greater precision between Alzheimer's disease and primary tauopathies, which facilitates earlier and more precise diagnosis and supports personalized treatment strategies," says principal investigator Professor Matthias Brendel, acting director of the Department of Nuclear Medicine.
Expanding radiotherapy access, a critical solution to India's rising cancer burden
The lack of accessibility and affordability of cancer care services in the hinterlands significantly impacts patient outcomes, particularly in areas like rural India where the majority of the population resides. Despite global advances in cancer treatment, the uneven distribution of healthcare resources means that many patients in these regions do not receive timely or appropriate care: De Misouard
Strand Life Sciences launch Somatic Advantage 74 Liquid Biopsy (SA74 LB) Test
The test utilises unique molecular identifiers (UMIs) to ensure high-confidence detection of genetic variants, making it a reliable tool for identifying potential biomarkers and guiding treatment decisions. Strand’s CAP and NABL accredited lab ensures rigorous quality standards and adherence to international best practices. The SA74 LB Test covers genomic alterations in 74 clinically relevant genes associated with therapy selection for solid tumours recommended by FDA and NCCN guidelines.
Polymed lines up ₹750 crore for expansion, buys over two years
The company last month raised ₹1,000 crore through qualified institutional placement (QIP) and has ₹150 crore as free cash flow to fund its growth plans.
Molbio Diagnostics' Truenat System improving TB detection, treatment initiation in high-burden Nigeria
The deployment of Truenat led to an increase in the TB case detection rate, with the proportion of TB-positive cases rising from 1633 (8 per cent of 20,424 tested) to 3338 (9 per cent of 37,087 tested), an additional 1704 cases in the nine months following the system's implementation. The detection of rifampicin-resistant TB (DR-TB) cases increased by 4.5 times post-implementation (from 7 to 32), indicating a significant advancement in addressing drug-resistant strains of TB, which are critical to managing and addressing the global TB crisis.
Accuray introduces Helix system to help transform cancer treatment in India
Accuray Helix brings flexibility and versatility and is intended to drive improvements in personalisation and patient care, while simultaneously facilitating treatment of more patients each day, boosting productivity for clinics and enabling them to efficiently manage the growing demand for cancer care. It allows healthcare providers to address a broad range of cancer types, making it a game changer for clinics in smaller cities.
1 in every 3 thyroid tests in Delhi NCR shows abnormal results
Data collected from 35,000 tests over the past six months indicates that approximately 33 percent of patients undergoing thyroid tests receive abnormal results, with 75 percent of these abnormalities occurring in females and 25 percent in males.
Abbott follows rival Dexcom with OTC glucose monitor launch in US
Lingo is available for consumers 18 years and older not on insulin in three payment options - $49 for two weeks, $89 for four weeks and $249 for 12 weeks, the company said on Thursday. Each biosensor can be worn for up to two weeks.
Nucleome Informatics launches gene test for detecting inherited retinal diseases
DrSeq IRD panel helps identify the genetic mutations responsible for specific IRD types, enabling patients to qualify for clinical trials or access targeted treatments tailored to their genetic profiles. One unique aspect of the test is its saliva-based collection method, which eliminates the need for blood samples, stated Nucleome.
Oxymed launches P2 Portable Oxygen Concentrator for Indian market
The oxygen concentrator weighs 1.98 kg and delivers oxygen with a purity level of 90-95 per cent across all flow rates, ensuring that users receive the essential oxygen support they need. The device offers up to five pulse flow settings, catering to various oxygen needs, and is equipped with a long-lasting battery that can provide up to 10 hours of use with a double battery.
Redcliffe Labs achieves Six Sigma score or above
Six Sigma metrics is a world-class methodology designed to improve laboratory processes by reducing defects and errors, minimising variation, and enhancing quality and efficiency. A score of three sigma is the minimum acceptable level, reflecting 6.68 per cent defects per million. At five sigma, the defect rate drops to 0.023 per cent per million, while a six-sigma score represents 0.0003 per cent defects per million which means 99.99966 per cent of the process output meets test accuracy requirements.
Wearable devices could help detect early signs of COVID-19, heart conditions, study suggests
Wearable devices that track one's physical activity, such as smartwatches, could help detect early signs of disease, including COVID-19, heart conditions and falls, a new study has suggested. Researchers from the University of South Australia reviewed 28 studies, including 12 lakh participants, and found that smartwatches and activity trackers could correctly identify COVID-19 status in 88 out of 100 people, similar to results from rapid screening tests.
Eyeing Big Plans, Gene Sequencing leader Illumina adds India to its GCC network
Illumina held a meeting of leading clinicians and scientists drawn from a spectrum of academic institutions, government and private sector labs to deliberate on the future of genomic science and its direct impact on healthcare.
Medical Device Park in Himachal to provide 10,000 jobs, says industries minister
The minister said that the state government will bear the entire expenditure on the project which is expected to be completed by December 31, 2025. No technical sanction was pending and there is possibility of setting up 65 industrial units under the project, he added.
Haematology lab with apheresis machine to come up in Uttarakhand
An apheresis machine, valued at approximately Rs 40 lakh, that will be installed in the lab is capable of producing 30,000 to 40,000 platelets per unit of blood, significantly more than conventional machines, which yield only 3,000 to 4,000 platelets per unit.
Himachal Pradesh to return Centre's Rs 30 cr for medical device park
"We will implement the project on terms that are favourable to the state," Himachal Pradesh chief minister Sukhvinder Sukhu told ET. "Had we taken the central investment, it would have meant providing land at Rs 1 per square metre, electricity for Rs 3 per unit and water, maintenance and warehouse facilities free of cost for 10 years."
Redcliffe Labs launches test for Mpox
The company has proactively assured key health authorities, including Noida's Chief Medical Officer (CMO) and the Indian Council of Medical Research (ICMR), of its readiness to manage the Mpox situation. Being prepared with advanced testing facilities not only ensures the rapid identification and isolation of cases but also guarantees that healthcare providers are fully equipped to handle increased demand.
India to offer 20% capital subsidy for domestic production of medtech components
India is known as the pharmacy of the world because of its generic medicines and low-cost vaccines. It has the highest number of United States Food and Drug Administration (USFDA) compliant Pharma plants outside of the USA. However, in the medical devices sector, the country remains heavily dependent on imports with nearly 70% of the products being sourced from other countries.
Cambrian Bioworks secures $1.45 million in seed funding
The funding will accelerate the development of the company’s automated molecular diagnostics platforms, bolster R&D efforts, expand the team, and support forays into international markets.
IASST develops new smart sensor for adjusting drug dosage to manage Parkinson’s Disease
It helps in compensating the deficiency of dopamine. As long as the correct amount of L-dopa is administered, the disease remains manageable. However, due to the progressive nature of Parkinson's, as the patient ages, more L-dopa is needed to compensate for the ongoing loss of neurons, the ministry said in a statement on Tuesday.
Metropolis healthcare launches two laboratories in Telangana
As part of the company's strategic plan to expand its footprint across tier II and tier III cities, Metropolis Healthcare has launched two new laboratories equipped to process over 15,000 samples per month. These facilities offer a comprehensive range of tests, from basic pathology to advanced molecular diagnostics.
Japanese delegation visits AIIMS Delhi to collaborate on National Centre for Medical Device Development, Validation and Skill Training
Leading the Japanese delegation was Kiyokazu Nakajima, Professor in the Department of Next Generation Endoscopic Intervention at Osaka University Graduate School of Medicine. The discussions revolved around the technical aspects and proposals for creating a state-of-the-art, publicly-funded research centre for medical device development, validation and skill training
Diagnostics firm Labcorp weighs ramping up mpox testing capacity
A new form of the virus has triggered global concern as it seems to spread easily though routine close contact, prompting the World Health Organization to declare mpox a global public health emergency this month.
Dexcom announces launch of over-the-counter continuous glucose monitor
Dexcom's Stelo uses a wearable sensor, paired with an application on the user's smartphone or other smart device to continuously measure blood glucose levels.
Affordable TB testing technology developed by ICMR's regional centre
The Indian Council of Medical Research (ICMR) has now invited Expression of Interest (EoI) from eligible organisations, companies, manufacturers for undertaking 'Transfer of Technology' for commercialisation of the 'A CRISPR case-based TB detection system' for the detection of Mycobacterium tuberculosis.
US FDA approves Abbott's aspirin free regimen for patients with HeartMate 3 heart pump
The ARIES-HM3 trial showed that patients who received the HeartMate 3 heart pump but didn't take aspirin as part of their blood-thinning medication regimen had nearly 40 per cent fewer complications from bleeding without increasing the risk of forming a blood clot compared to patients who also received a HeartMate 3 but did take aspirin.
NEWS AND UPDATES
Stay updated with the latest healthcare news
Krsnaa Diagnostics acquires strategic stake in Apulki Healthcare
With this acquisition, Krsnaa aims to provide a comprehensive suite of integrated diagnostic services to cancer and cardiac patients under one roof, the company said in a statement.
NCDRC directs Johnson & Johnson to pay Rs 35 lakh for faulty hip replacement device
But, as the device had a high rate of failure and caused severe injuries to the patients, DePuy voluntarily recalled two devices, ASR XL Acetabular and ASR Hip Resurfacing system in September 2010. The opposite parties, Johnson & Johnson Limited and DePuy Orthopaedics Inc were a group of companies of Johnson & Johnson, USA, a leader in the global orthopaedic industry, said Lohia's plea.
Metropolis Healthcare launches ‘Healthy Heart Meter’ campaign in honour of World Heart Day
The initiative aims to encourage preventive care and raise awareness about heart health. The campaign features a simple 10-question survey to help individuals assess their risk factors based on lifestyle choices, medical history, and basic health indicators. Based on their responses, participants are identified as—low, medium, or high risk as per the heart meter. Those identified as medium risk will be recommended to take a non-fasting lipid profile test, while those at high risk will be suggested to take the comprehensive ‘Truhealth Heart Meter Pack’ which includes various diagnostic tests to assess heart health, with the option of an ECG.
Stryker Launches Next-Gen Surgical Camera in India, Enhancing Visualization Across Specialties
The 1788 platform delivers high-resolution images that enable surgeons to visualize critical anatomy with greater clarity. It features advanced fluorescence imaging capabilities, offering clearer perfusion imaging and detailed visualization of complex anatomical structures, Stryker said.
String test may improve diagnosis, treatment of ulcers: Nobel laureate
The other end of the string travels through the digestive system, collecting samples of mucus and bacteria. The string is removed and analysed. "The string test and quantitative PCR (qPCR) confirm the diagnosis and tell us about the best antibiotic for treatment," he said. "Research on the test is still ongoing, but we know it is showing some promise," he said. The test, if proven, may improve the diagnosis and treatment of ulcers.
Amid mpox outbreak South Korea's PCR system markets to grow at 5% till 2033: GlobalData
As per a market study by GlobalData, amid the rising cases of mpox in the world, coupled development of several new tests is going to have a positive impact and the South Korean PCR systems market is expected to grow at a CAGR of 5 per cent through 2033.
Blood test could identify children at risk of obesity-related conditions, lipid analysis suggests
They analysed blood samples of over 1,300 obese, overweight and normal-weight children and identified new lipid molecules which contribute to health risks like blood pressure, but are not only related with a child's weight.
IRGMA welcomes CDSCO's new guidelines, urges stringent measures to curb substandard gloves import
The association has long been demanding the Quality Control Order (QCO) for gloves to keep substandard imports at bay and urged the government to expedite its process. This will not only help Indian manufacturers but also contribute to the union government’s Make in India initiative to achieve self-sufficiency and reduce dependence on other countries.
The Necessity of Comprehensive Flu Testing Packages to Minimise Repeated Examinations
Comprehensive testing packages with a broad detection capability, ensure that multiple pathogens are identified in one go, which further helps in delivering accurate diagnoses and appropriate treatments. Additionally, these packages play a vital role in public health by monitoring circulating strains, managing influenza outbreaks effectively and minimizing their impact on public health.
FDA recall orders for McGrath Mac’s Medtronic laryngoscope may hurt device sales: GlobalData
According to GlobalData, the decision of the US regulator is likely to hurt Medtronic's sales, which currently occupies approximately 10.3 per cent of the laryngoscope market. This impact is compounded by competition from major players like Ambu, Karl Storz, and Olympus, which hold market shares of 13.4 per cent , 15.1 per cent , and 18.1 per cent , respectively.
Redcliffe Labs launch Gut Microbiome, HealthEx tests to promote preventive healthcare
The Gut Microbiome test is a non-invasive and reliable health test that comprehensively analyses gut health. This test recognises that gut microbiota is unique to every person, varying based on gender, geography, eating habits, culture, genetics, and lifestyle. HealthEx is an advanced blood test that evaluates an individual's DNA to provide detailed health insights into potential risks one may develop due to current lifestyle, diet, and genetic factors.
Artificial heart maker Carmat's shares slide on $11.5 mln capital hike
"The capital increase with a priority period for shareholders that we are launching today is crucial to strengthen our short-term financial structure", CEO Stephane Piat said in a statement.
Redcliffe Labs raises $42 million in Series C funding
The organisation will use the funds to open more labs and collection centres along with an expansion of its home collection network. The company has successfully executed strategic acquisitions in North-Western India and continues to pursue a PAN-India expansion through strategic partnerships and further acquisitions.
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
Founded in 2016 by Musk and a group of engineers, Neuralink is building a brain chip interface that can be implanted within the skull, which it says could eventually help disabled patients to move and communicate again, and also restore vision.
Researchers find new diagnostic algorithm to differentiate between Alzheimer's disease, primary tauopathies
"The new diagnostic algorithm we developed allows physicians to differentiate with greater precision between Alzheimer's disease and primary tauopathies, which facilitates earlier and more precise diagnosis and supports personalized treatment strategies," says principal investigator Professor Matthias Brendel, acting director of the Department of Nuclear Medicine.
Expanding radiotherapy access, a critical solution to India's rising cancer burden
The lack of accessibility and affordability of cancer care services in the hinterlands significantly impacts patient outcomes, particularly in areas like rural India where the majority of the population resides. Despite global advances in cancer treatment, the uneven distribution of healthcare resources means that many patients in these regions do not receive timely or appropriate care: De Misouard
Strand Life Sciences launch Somatic Advantage 74 Liquid Biopsy (SA74 LB) Test
The test utilises unique molecular identifiers (UMIs) to ensure high-confidence detection of genetic variants, making it a reliable tool for identifying potential biomarkers and guiding treatment decisions. Strand’s CAP and NABL accredited lab ensures rigorous quality standards and adherence to international best practices. The SA74 LB Test covers genomic alterations in 74 clinically relevant genes associated with therapy selection for solid tumours recommended by FDA and NCCN guidelines.
Polymed lines up ₹750 crore for expansion, buys over two years
The company last month raised ₹1,000 crore through qualified institutional placement (QIP) and has ₹150 crore as free cash flow to fund its growth plans.
Molbio Diagnostics' Truenat System improving TB detection, treatment initiation in high-burden Nigeria
The deployment of Truenat led to an increase in the TB case detection rate, with the proportion of TB-positive cases rising from 1633 (8 per cent of 20,424 tested) to 3338 (9 per cent of 37,087 tested), an additional 1704 cases in the nine months following the system's implementation. The detection of rifampicin-resistant TB (DR-TB) cases increased by 4.5 times post-implementation (from 7 to 32), indicating a significant advancement in addressing drug-resistant strains of TB, which are critical to managing and addressing the global TB crisis.
Accuray introduces Helix system to help transform cancer treatment in India
Accuray Helix brings flexibility and versatility and is intended to drive improvements in personalisation and patient care, while simultaneously facilitating treatment of more patients each day, boosting productivity for clinics and enabling them to efficiently manage the growing demand for cancer care. It allows healthcare providers to address a broad range of cancer types, making it a game changer for clinics in smaller cities.
1 in every 3 thyroid tests in Delhi NCR shows abnormal results
Data collected from 35,000 tests over the past six months indicates that approximately 33 percent of patients undergoing thyroid tests receive abnormal results, with 75 percent of these abnormalities occurring in females and 25 percent in males.
Abbott follows rival Dexcom with OTC glucose monitor launch in US
Lingo is available for consumers 18 years and older not on insulin in three payment options - $49 for two weeks, $89 for four weeks and $249 for 12 weeks, the company said on Thursday. Each biosensor can be worn for up to two weeks.
Nucleome Informatics launches gene test for detecting inherited retinal diseases
DrSeq IRD panel helps identify the genetic mutations responsible for specific IRD types, enabling patients to qualify for clinical trials or access targeted treatments tailored to their genetic profiles. One unique aspect of the test is its saliva-based collection method, which eliminates the need for blood samples, stated Nucleome.
Oxymed launches P2 Portable Oxygen Concentrator for Indian market
The oxygen concentrator weighs 1.98 kg and delivers oxygen with a purity level of 90-95 per cent across all flow rates, ensuring that users receive the essential oxygen support they need. The device offers up to five pulse flow settings, catering to various oxygen needs, and is equipped with a long-lasting battery that can provide up to 10 hours of use with a double battery.
Redcliffe Labs achieves Six Sigma score or above
Six Sigma metrics is a world-class methodology designed to improve laboratory processes by reducing defects and errors, minimising variation, and enhancing quality and efficiency. A score of three sigma is the minimum acceptable level, reflecting 6.68 per cent defects per million. At five sigma, the defect rate drops to 0.023 per cent per million, while a six-sigma score represents 0.0003 per cent defects per million which means 99.99966 per cent of the process output meets test accuracy requirements.
Wearable devices could help detect early signs of COVID-19, heart conditions, study suggests
Wearable devices that track one's physical activity, such as smartwatches, could help detect early signs of disease, including COVID-19, heart conditions and falls, a new study has suggested. Researchers from the University of South Australia reviewed 28 studies, including 12 lakh participants, and found that smartwatches and activity trackers could correctly identify COVID-19 status in 88 out of 100 people, similar to results from rapid screening tests.
Eyeing Big Plans, Gene Sequencing leader Illumina adds India to its GCC network
Illumina held a meeting of leading clinicians and scientists drawn from a spectrum of academic institutions, government and private sector labs to deliberate on the future of genomic science and its direct impact on healthcare.
Medical Device Park in Himachal to provide 10,000 jobs, says industries minister
The minister said that the state government will bear the entire expenditure on the project which is expected to be completed by December 31, 2025. No technical sanction was pending and there is possibility of setting up 65 industrial units under the project, he added.
Haematology lab with apheresis machine to come up in Uttarakhand
An apheresis machine, valued at approximately Rs 40 lakh, that will be installed in the lab is capable of producing 30,000 to 40,000 platelets per unit of blood, significantly more than conventional machines, which yield only 3,000 to 4,000 platelets per unit.
Himachal Pradesh to return Centre's Rs 30 cr for medical device park
"We will implement the project on terms that are favourable to the state," Himachal Pradesh chief minister Sukhvinder Sukhu told ET. "Had we taken the central investment, it would have meant providing land at Rs 1 per square metre, electricity for Rs 3 per unit and water, maintenance and warehouse facilities free of cost for 10 years."
Redcliffe Labs launches test for Mpox
The company has proactively assured key health authorities, including Noida's Chief Medical Officer (CMO) and the Indian Council of Medical Research (ICMR), of its readiness to manage the Mpox situation. Being prepared with advanced testing facilities not only ensures the rapid identification and isolation of cases but also guarantees that healthcare providers are fully equipped to handle increased demand.
India to offer 20% capital subsidy for domestic production of medtech components
India is known as the pharmacy of the world because of its generic medicines and low-cost vaccines. It has the highest number of United States Food and Drug Administration (USFDA) compliant Pharma plants outside of the USA. However, in the medical devices sector, the country remains heavily dependent on imports with nearly 70% of the products being sourced from other countries.
Cambrian Bioworks secures $1.45 million in seed funding
The funding will accelerate the development of the company’s automated molecular diagnostics platforms, bolster R&D efforts, expand the team, and support forays into international markets.
IASST develops new smart sensor for adjusting drug dosage to manage Parkinson’s Disease
It helps in compensating the deficiency of dopamine. As long as the correct amount of L-dopa is administered, the disease remains manageable. However, due to the progressive nature of Parkinson's, as the patient ages, more L-dopa is needed to compensate for the ongoing loss of neurons, the ministry said in a statement on Tuesday.
Metropolis healthcare launches two laboratories in Telangana
As part of the company's strategic plan to expand its footprint across tier II and tier III cities, Metropolis Healthcare has launched two new laboratories equipped to process over 15,000 samples per month. These facilities offer a comprehensive range of tests, from basic pathology to advanced molecular diagnostics.
Japanese delegation visits AIIMS Delhi to collaborate on National Centre for Medical Device Development, Validation and Skill Training
Leading the Japanese delegation was Kiyokazu Nakajima, Professor in the Department of Next Generation Endoscopic Intervention at Osaka University Graduate School of Medicine. The discussions revolved around the technical aspects and proposals for creating a state-of-the-art, publicly-funded research centre for medical device development, validation and skill training
Diagnostics firm Labcorp weighs ramping up mpox testing capacity
A new form of the virus has triggered global concern as it seems to spread easily though routine close contact, prompting the World Health Organization to declare mpox a global public health emergency this month.
Dexcom announces launch of over-the-counter continuous glucose monitor
Dexcom's Stelo uses a wearable sensor, paired with an application on the user's smartphone or other smart device to continuously measure blood glucose levels.
Affordable TB testing technology developed by ICMR's regional centre
The Indian Council of Medical Research (ICMR) has now invited Expression of Interest (EoI) from eligible organisations, companies, manufacturers for undertaking 'Transfer of Technology' for commercialisation of the 'A CRISPR case-based TB detection system' for the detection of Mycobacterium tuberculosis.
US FDA approves Abbott's aspirin free regimen for patients with HeartMate 3 heart pump
The ARIES-HM3 trial showed that patients who received the HeartMate 3 heart pump but didn't take aspirin as part of their blood-thinning medication regimen had nearly 40 per cent fewer complications from bleeding without increasing the risk of forming a blood clot compared to patients who also received a HeartMate 3 but did take aspirin.